Key result
Review outlines tailored diabetes management and cardiovascular risk reduction strategies in HIV-infected patients.
Answers are grounded in this paper and cite their sources.
Diabetes mellitus (DM) is a common condition with significant associated morbidity and mortality. DM diagnosis and management among human immunodeficiency virus (HIV)-infected patients is a particularly relevant topic as the HIV-infected population ages and more HIV-infected individuals live with chronic medical comorbidities. Although there is mixed evidence regarding HIV as an independent risk factor for DM, multiple factors related to HIV and its treatment are associated with DM. This review covers the epidemiology of DM in HIV-infected patients, and diagnosis, management, and treatment goals for DM in HIV-infected patients. We highlight the most recent DM treatment guidelines from the American Diabetes Association and the European Association for the Study of Diabetes, emphasizing individualization of DM medication therapy and treatment goals. Finally, we review a comprehensive approach to cardiovascular disease risk reduction in HIV-infected patients with DM and measures to prevent other complications of DM.
No takes yet. Share an insight, caveat, or question.
Monroe et al. (2014) conducted a review in Diabetes mellitus in HIV-infected patients. Diabetes diagnosis and management was evaluated. This review summarizes current guidelines for diagnosing and managing diabetes in HIV-infected patients, emphasizing individualized medication therapy and cardiovascular risk reduction.
Synapse has enriched 5 related papers. Consider them for comparative context: